Srikala S. Sridhar

University Health Network

Papers

1

Total Citations

8

H-Index

1

About

Srikala S. Sridhar is a leading oncologist whose work focuses on the intersection of surgical innovation and systemic therapy for genitourinary cancers, particularly muscle-invasive bladder cancer. Her major contributions center on evaluating the comparative effectiveness of robot-assisted versus open radical cystectomy in patients receiving perioperative chemotherapy, a critical question that shapes treatment paradigms for this aggressive disease. Through her involvement in a multicentre study, Sridhar provided the oncologist’s perspective on how surgical approach impacts outcomes, offering nuanced insights into the balance between technical advances and patient survival. While her most-cited paper has accumulated 8 citations, its influence lies in its timely relevance to ongoing debates about minimally invasive surgery in oncology. Sridhar’s work exemplifies the collaborative, multidisciplinary approach needed to optimize care for bladder cancer patients, bridging surgical and medical oncology to improve both treatment delivery and long-term results. Her research continues to inform clinical decision-making for one of the most challenging urologic malignancies.

Research Focus

Key Achievements

1
H-Index
1
Papers
8
Total Citations
8
Avg Citations/Paper
🏆 Most Cited Paper
Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist’s Perspective from a Multicentre Study
8 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 34
🏛 Institutions: University Health Network

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 12 days ago